Ill-defined disorder and Hepatitis toxic

Summary:

Hepatitis toxic is found among people with Ill-defined disorder, especially for people who are female, 60+ old.

The study analyzes which people have Hepatitis toxic with Ill-defined disorder. It is created by eHealthMe based on reports of 15 people who have Ill-defined disorder from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Ill-defined disorder?

Ill-defined disorder is found to be associated with 1,461 drugs and 1,258 conditions by eHealthMe. Check the latest studies of Ill-defined disorder.

What is Hepatitis toxic?

Hepatitis toxic is found to be associated with 281 drugs and 524 conditions by eHealthMe. Check the latest studies of Hepatitis toxic.



On Aug, 01, 2026

15 people who have Ill-Defined Disorder and Hepatitis Toxic are studied.

Would you have Hepatitis toxic when you have Ill-defined disorder?

Gender of people who have Ill-Defined Disorder and experienced Hepatitis Toxic *:

  • female: 60 %
  • male: 40 %

Age of people who have Ill-Defined Disorder and experienced Hepatitis Toxic *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 8.33 %
  • 30-39: 0.0 %
  • 40-49: 16.67 %
  • 50-59: 33.33 %
  • 60+: 41.67 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 4 people, 26.67%
  2. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 20.00%
  3. Gastritis (inflammation of stomach): 2 people, 13.33%
  4. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 13.33%
  5. Urinary Tract Infection: 1 person, 6.67%
  6. Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 1 person, 6.67%
  7. Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.67%
  8. Heart Disease: 1 person, 6.67%

Common drugs taken by these people *:

  1. Clopidogrel Bisulfate: 4 people, 26.67%
  2. Enalapril Maleate: 4 people, 26.67%
  3. Levothyroxine Sodium: 4 people, 26.67%
  4. Amlodipine: 3 people, 20.00%
  5. Atorvastatin Calcium: 3 people, 20.00%
  6. Simvastatin: 3 people, 20.00%
  7. Hydrochlorothiazide: 3 people, 20.00%
  8. Metoprolol Tartrate: 2 people, 13.33%
  9. Carbamazepine: 2 people, 13.33%
  10. Vaseretic: 2 people, 13.33%

Common symptoms for these people *:

  1. Hepatomegaly (abnormal enlargement of the liver): 4 people, 26.67%
  2. Blood Glucose Increased: 3 people, 20.00%
  3. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 13.33%
  4. Blood Creatine Increased: 2 people, 13.33%
  5. High Blood Pressure: 2 people, 13.33%
  6. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 13.33%
  7. Haemoglobin Decreased: 2 people, 13.33%
  8. Haematocrit Decreased: 2 people, 13.33%
  9. Blood Albumin Decreased: 2 people, 13.33%
  10. Pneumonia: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hepatitis toxic?

- Check whether Hepatitis toxic is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hepatitis toxic:

All the conditions that are associated with Hepatitis toxic:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hepatitis toxic and Ill-defined disorder, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: